ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$0.32
+0.02 (+5.00%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+15,769.8% upside
Low Target
$34.23
Average Target
$49.99
High Target
$60.95
Current Price
$0.32
Current
$0.32
$0.32
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Scenario Analysis
Bear Case
$34.23
10,766.7%
Low target
Base Case
$49.99
+15,769.8%
Avg target
Bull Case
$60.95
+19,249.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$49.99
+1,654.0% vs high
Next Earnings Report
Sep 28, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.10
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |